Jennifer Chen argues cancer recovery creates a moving target

In a personal column published on October 9, 2026, in NRC, health columnist and patient Jennifer Chen examines the psychological aftermath of surviving cancer treatment and the inadequacy of standard recovery models that treat the illness as a finished chapter. Chen argues that patients exiting intensive therapies face a persistent moving target sensation rather than a clear boundary between sickness and health.

The Fallacy of Standard Recovery Stages

Chen compares the trajectory commonly outlined by healthcare providers to rigid psychological frameworks like the five stages of grief. Medical support staff initially mapped out a familiar progression for her ovarian cancer treatment, outlining a path of shock followed by survival mode, and ultimately, realization. While Chen acknowledges that her treatment indeed functioned as an obstacle race focused purely on survival, she disputes the neat resolution implied by the final phase.

Recovery often gets framed by enthusiastic narratives found in online patient groups, where individuals declare they are living their best lives by quitting jobs or taking cruises. In contrast, Chen writes that her own post-chemotherapy reality is far less epic. The realization phase brought awareness that life is permanently altered, oscillating unpredictably between normal days and palliate-leaning states.

Statistical Realities of Modern Cancer Care

The Netherlands Comprehensive Cancer Organisation (Integraal Kankercentrum) reported on October 7, 2026, that cancer diagnoses will continue to increase in the coming years. However, the data also shows that cancer is becoming less lethal. Thirty years ago, only half of patients survived five years past their diagnosis, whereas the five-year survival rate has now risen to 71 percent. Modern medical advancements, including immunotherapies that successfully treat skin cancer patients who would have been given up on a decade ago, mean more people are surviving.

This medical progress shifts the baseline of the disease. Kanker is increasingly transforming into a chronic condition rather than an acute crisis, making traditional labels like palliative care inadequate for patients who are neither clearly terminal nor fully cured.

Between Remission and Recurrence

Hospital psychological support systems struggle to accommodate this grey area, offering groups strictly divided between patients aiming to resume normal life and those facing terminal prognoses. Chen notes that neither category fits her situation, as she experiences jealousy toward successfully treated breast cancer patients and depression around incurable peers. Because ovarian cancer carries a high risk of recurrence alongside her positive initial response to chemotherapy, standard medical statistics fail to clarify whether she is experiencing an interbellum or a durable peace.

Social circles frequently misinterpret physical recovery, such as regrowing hair and returning to work, as complete healing. When Chen explains that she may never return to her previous state, acquaintances express confusion. According to her gynecologist, her specific medical situation remains too atypical for statistics to offer precise predictions about her future, leaving her with a zero percent chance of feeling entirely carefree in the immediate years ahead.